SCHEMBL5138522

SCHEMBL5138522

O=c1oc2ccccc2c(O)c1[N+](=O)[O-]

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 9/20 0.67
MAPT P10636 6/20 0.61
KMT2A Q03164 5/20 0.60
MEN1 O00255 4/20 0.60
GAA P10253 3/20 0.60
POLB P06746 2/20 0.60
ALDH1A1 P00352 6/20 0.58
HTT P42858 2/20 0.58
PKM P14618 1/20 0.58
KDM4E B2RXH2 2/20 0.58
RECQL P46063 1/20 0.58
GALK1 P51570 1/20 0.58
L3MBTL1 Q9Y468 1/20 0.58
S100A4 P26447 1/20 0.56
NPC1 O15118 1/20 0.55
RAB9A P51151 1/20 0.55
CA12 O43570 1/20 0.55
CA9 Q16790 1/20 0.55
GPR55 Q9Y2T6 1/20 0.55
HPGD P15428 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17330278 0.88 LMNA (0.53) LMNAMAPTKMT2AMEN1GAA
SCHEMBL17347333 0.85 KDM4E (0.57) LMNAMAPTKMT2AMEN1GAA
SCHEMBL11848796 0.81 NQO1 (0.56) LMNAMAPTKMT2AMEN1GAA
SCHEMBL30272141 0.80 LMNA (0.67) LMNAMAPTKMT2AMEN1GAA
SCHEMBL17844954 0.80 LMNA (1.00) LMNAMAPTKMT2AMEN1GAA
SCHEMBL2017838 0.80 LMNA (0.67) LMNAMAPTKMT2AMEN1GAA
SCHEMBL21645618 0.80 LMNA (0.67) LMNAMAPTKMT2AMEN1GAA
SCHEMBL3680356 0.80 LMNA (0.67) LMNAMAPTKMT2AMEN1GAA
SCHEMBL11852487 0.80 CA9 (0.68) LMNAMAPTKMT2AMEN1POLB
SCHEMBL27886686 0.79 CSNK2A2 (0.52) LMNAMAPTKMT2AMEN1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108598533-B Coumarin-based photocyclization crosslinking sulfonated polyimide proton exchange membrane and preparation method thereof 同济大学 2020-11-03 CN claimed
US-9870909-B2 Compositions and methods for mass spectometry MSTM, LLC 2018-01-16 US claimed
US-12486293-B2 Chirality sensing with molecular click chemistry probes GEORGETOWN UNIVERSITY (US) 2025-12-02 US disclosed
CN-118834490-A Photo-crosslinkable perfluorinated ion membrane and preparation method thereof 上海交通大学 2024-10-25 CN disclosed
US-20220380395-A1 CHIRALITY SENSING WITH MOLECULAR CLICK CHEMISTRY PROBES GEORGETOWN UNIVERSITY 2022-12-01 US disclosed
CN-108598533-B Coumarin-based photocyclization crosslinking sulfonated polyimide proton exchange membrane and preparation method thereof 同济大学 2020-11-03 CN disclosed
WO-2020028396-A1 CHIRALITY SENSING WITH MOLECULAR CLICK CHEMISTRY PROBES GEORGETOWN UNIVERSITY (US) 2020-02-06 WO disclosed
US-9870909-B2 Compositions and methods for mass spectometry MSTM, LLC 2018-01-16 US disclosed
US-9870909-B2 Compositions and methods for mass spectometry MSTM, LLC 2018-01-16 US disclosed
US-20150364311-A1 COMPOSITIONS AND METHODS FOR MASS SPECTOMETRY MSTM, LLC 2015-12-17 US disclosed
CN-105017195-A 4-hydroxycoumarin-3-Schiff base derivate and use thereof for curing Alzheimer's disease UNIV CHINA PHARMA 2015-11-04 CN disclosed
WO-2007115181-A9 COMPOUNDS EXHIBITING EFFLUX INHIBITOR ACTIVITY AND COMPOSITIONS AND USES THEREOF EASTMAN CHEM CO (US) 2008-04-03 WO disclosed
US-20070254859-A1 Compounds exhibiting efflux inhibitor activity and composition and uses thereof EASTMAN CHEMICAL COMPANY 2007-11-01 US disclosed
WO-2007115181-A2 COMPOUNDS EXHIBITING EFFLUX INHIBITOR ACTIVITY AND COMPOSITIONS AND USES THEREOF EASTMAN CHEMICAL COMPANY (US) 2007-10-11 WO disclosed
US-4716222-A CHROMOGENS, SPECTROPHOTOMETRY HOECHST AKTIENGESELLSCHAFT (DE) 1987-12-29 US disclosed
EP-0157384-A2 Substrates for hydrolases, process for their preparation and their use Biomed Labordiagnostik GmbH (DE) 1985-10-09 EP disclosed
EP-0050396-B1 COUMARIN INTERMEDIATES BEECHAM GROUP PLC (GB) 1984-12-27 EP disclosed
EP-0010392-B1 HETEROCYCLIC COUMARIN DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAID DERIVATIVES BEECHAM GROUP PLC (GB) 1982-12-29 EP disclosed
EP-0050396-A1 Coumarin intermediates BEECHAM GROUP PLC (GB) 1982-04-28 EP disclosed
US-3974289-A Coumarin derivatives for the treatment of allergies BEECHAM GROUP LIMITED (EN) 1976-08-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070254859-A1 Compounds exhibiting efflux inhibitor activity and composition and uses thereof ABCC4, NCOA4, NR4A3 LMNA 4191/4885MAPT 4566/4885KMT2A 4362/4885
US-20220380395-A1 CHIRALITY SENSING WITH MOLECULAR CLICK CHEMISTRY PROBES PTMS, NISCH, CHAMP1 LMNA 2928/4885MAPT 4815/4885KMT2A 4568/4885
US-12486293-B2 Chirality sensing with molecular click chemistry probes PTMS, NISCH, CHAMP1 LMNA 2928/4885MAPT 4815/4885KMT2A 4568/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.